COCHLEAR LIMITED — Regulatory Filings 2009

Sep 3, 2009

==> picture [595 x 54] intentionally omitted <==

==> picture [595 x 54] intentionally omitted <==

ASX / MEDIA RELEASE 4 September 2009

COCHLEAR LIMITED: FDA APPROVAL FOR NUCLEUS 5 SYSTEM

Cochlear Limited (ASX:COH) advised today that it has received approval from the USA Food and Drug Administration of the two Premarket Approval Supplements covering the new Cochlear Nucleus 5 System.

The full system (implant and sound processor) will be released in the USA on 8 September 2009.

The new system includes the world's thinnest cochlear implant (40% thinner than Cochlear’s existing implant), the world's most advanced sound processor for a cochlear implant and a bi-directional remote assistant.

-ends-

Media contacts:

Company contacts:

Michael Mullane Dr Chris Roberts, CEO/President Cannings Corporate Communications p: + 61 2 9428 6555 p: +61 2 8284 9993 m: 0414 590 296 Neville Mitchell, CFO mmullane@cannings.net.au p: + 61 2 9428 6555

Craig Badings Cannings Corporate Communications p: +61 2 8284 9991 m: 0413 946 703 cbadings@cannings.net.au

1